Obesity Drug
- All
- News
- Videos
-
Obesity: Why New Medications Are Not Miracle Cures
- Friday November 7, 2025
- Health | The Conversation
Recently, new drugs - analogs of the gut hormone glucagon-like peptide-1 (GLP-1) have been added to the therapeutic arsenal, raising new hopes. However, they alone will not be enough to conquer obesity.
-
www.ndtv.com
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
- Thursday October 30, 2025
- Health | Written by NDTV Health Desk
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
www.ndtv.com
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
- Wednesday September 17, 2025
- Health | Naomi Kresge And Madison Muller, Bloomberg
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
www.ndtv.com
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
- Monday September 15, 2025
- Health | Indo-Asian News Service
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
www.ndtv.com
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
- Wednesday September 10, 2025
- Health | Written by Shreya Goswami
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
www.ndtv.com
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
- Wednesday September 10, 2025
- World News | Agence France-Presse
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
www.ndtv.com
-
Could Dogs Get Their Version Of Ozempic? Scientists Test "Ozempup" For Pet Obesity
- Thursday August 21, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
Biotech firm Vivani Medical has joined hands with Okava to work on a canine-friendly version of weight loss medications
-
www.ndtv.com/lifestyle
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
- Sunday July 27, 2025
- Science | Edited by Ritu Singh
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
www.ndtv.com
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
- Tuesday July 8, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
www.ndtv.com/lifestyle
-
Weight Loss Ad Sparks Controversy: "Don't Promote Obesity, It's A lifestyle Disease," Say Experts
- Monday July 7, 2025
- Health | Varsha Vats
Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver and others.
-
www.ndtv.com
-
Are Mounjaro Jabs Safe? Mass Rollout Of Weight Loss Drug To Start In UK
- Monday June 23, 2025
- World News | Edited by Srishti Singh Sisodia
NHS to monitor the mass rollout that will see around 220,000 people with the "greatest need" receive the weight loss jabs.
-
www.ndtv.com
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
- Thursday March 20, 2025
- India News | Press Trust of India
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
www.ndtv.com
-
Biocon Launches Diabetes, Obesity Management Drug In UK
- Friday February 28, 2025
- World News | Press Trust of India
Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.
-
www.ndtv.com
-
Obesity: Why New Medications Are Not Miracle Cures
- Friday November 7, 2025
- Health | The Conversation
Recently, new drugs - analogs of the gut hormone glucagon-like peptide-1 (GLP-1) have been added to the therapeutic arsenal, raising new hopes. However, they alone will not be enough to conquer obesity.
-
www.ndtv.com
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
- Thursday October 30, 2025
- Health | Written by NDTV Health Desk
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
www.ndtv.com
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
- Wednesday September 17, 2025
- Health | Naomi Kresge And Madison Muller, Bloomberg
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
www.ndtv.com
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
- Monday September 15, 2025
- Health | Indo-Asian News Service
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
www.ndtv.com
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
- Wednesday September 10, 2025
- Health | Written by Shreya Goswami
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
www.ndtv.com
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
- Wednesday September 10, 2025
- World News | Agence France-Presse
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
www.ndtv.com
-
Could Dogs Get Their Version Of Ozempic? Scientists Test "Ozempup" For Pet Obesity
- Thursday August 21, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
Biotech firm Vivani Medical has joined hands with Okava to work on a canine-friendly version of weight loss medications
-
www.ndtv.com/lifestyle
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
- Sunday July 27, 2025
- Science | Edited by Ritu Singh
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
www.ndtv.com
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
- Tuesday July 8, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
www.ndtv.com/lifestyle
-
Weight Loss Ad Sparks Controversy: "Don't Promote Obesity, It's A lifestyle Disease," Say Experts
- Monday July 7, 2025
- Health | Varsha Vats
Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver and others.
-
www.ndtv.com
-
Are Mounjaro Jabs Safe? Mass Rollout Of Weight Loss Drug To Start In UK
- Monday June 23, 2025
- World News | Edited by Srishti Singh Sisodia
NHS to monitor the mass rollout that will see around 220,000 people with the "greatest need" receive the weight loss jabs.
-
www.ndtv.com
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
- Thursday March 20, 2025
- India News | Press Trust of India
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
www.ndtv.com
-
Biocon Launches Diabetes, Obesity Management Drug In UK
- Friday February 28, 2025
- World News | Press Trust of India
Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.
-
www.ndtv.com